Skip to Content

Tag: Triad Life Sciences


ConvaTec enters new market

January 31, 2022HME News Staff

BRIDGEWATER, N.J. – ConvaTec will enter the wound biologics segment with its planned acquisition of Memphis, Tenn.-based Triad Life Sciences for an initial consideration of $125 million.  The company says the wound biologics segment is estimated to be worth $1.8 billion per year globally.  “Today’s announcement marks another successful step in our strategic intent of pivoting to sustainable and profitable growth,” said Karim Bitar, CEO of ConvaTec. “This...

ConvaTec, Triad Life Sciences, Wound Care

Read Full Articlered right arrow icon